ABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Up to $14.32

ABIVAX Société Anonyme (NASDAQ:ABVX) gapped up before the market opened on Tuesday . The stock had previously closed at $14.32, but opened at $14.80. ABIVAX Société Anonyme shares last traded at $14.81, with a volume of 993 shares trading hands.

ABIVAX Société Anonyme Stock Down 0.3 %

The company’s 50-day moving average is $13.25.

Institutional Investors Weigh In On ABIVAX Société Anonyme

Several hedge funds have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC bought a new stake in ABIVAX Société Anonyme in the fourth quarter worth $249,000. Capstone Investment Advisors LLC bought a new stake in ABIVAX Société Anonyme in the fourth quarter worth $618,000. Ghisallo Capital Management LLC bought a new stake in ABIVAX Société Anonyme in the fourth quarter worth $642,000. Point72 Asset Management L.P. bought a new stake in ABIVAX Société Anonyme in the fourth quarter worth $4,488,000. Finally, Citadel Advisors LLC bought a new stake in ABIVAX Société Anonyme in the fourth quarter worth $7,842,000. 47.91% of the stock is owned by institutional investors.

ABIVAX Société Anonyme Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis.